Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment

Cell Death and Differentiation

Volumn 5, Issue 7, 1998, Pages 584-591

  Kobayashi, Tohru ^a,b   Ruan, Sanbao ^a   Jabbur, James R ^a   Consoli, Ugo ^a   Clodi, Katharina ^a   Shiku, Hiroshi ^b   Owen Schaub, Laurie B ^a   Andreeff, Michael ^a   Reed, John C ^c   Zhang, Wei ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; Ara C; Irradiation; p53 phosphorylation

Indexed keywords

CYTARABINE; FAS ANTIGEN; PHOSPHATASE; PROTEIN BAX; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; IRRADIATION; ISOELECTRIC POINT; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ARA;

EID: 7344231094     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400382     Document Type: Article

References (48)

1. Barak Y, Juven T, Haffner R and Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468
2. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka L, Mao X, Nunez G and Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74. 597-608
3. Clarke AR. Purdie CA, Hamson DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362 849-852
4. EI-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression Cell 75 817-825
5. Fiscelia M, Ullrich SJ, Zambrano N, Shields MT. Lin D, Lees-Miller SP, Anderson CW, Mercer WE and Appella E (1993) Mutation of the senne 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression Oncogene 8. 1519-1528
6. Gorczyca W, Gong J-P and Darzynkiewicz Z (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53. 1945-1951
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A Seto Y and Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
8. Kastan MB, Zhan Q, EI-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein Band Fornace AJ (1992) A mammalian cellcycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 587-597
9. WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene 11: 2311-2316
10. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-886
11. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG and Reed JC (1994) Immunohitostochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J Patrol 145. 1323-1336
12. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinantfollowing irradiation. Proc. Natl. Acad. Sci. USA 89: 7491-7495
13. Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW (1992) Human DNA-activated protein kinase phosphorylation serines 15 and 37 in the amino-terminal transactivation domain of human p53 Mol. Cell Biol 12: 5041-5049
14. Liu X, Kim CN, Yang J, Jemmerson R and Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 86: 147-157
15. Lowe SW, Ruley HE, Jacks T and Housman DE (1993a) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
16. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993b) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
17. Maxwell IH and Maxwell F (1988) Electroporation of mammalian cells with a firefly luciferase expression plasmid: kinetics of transient expression differ markedly among cell types. DNA 7: 557-562
18. Milne DM, Cambell LE, Cambell DG and Meek DW (1995) p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J. Biol Chem. 270: 5511-5518
19. Miyashita T, Harigai M, Hanada M and Reed JC (1994a) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135
20. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liberman DA, Hoffman B and Reed JC (1994b) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
21. Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80: 293-299
22. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-weber M, Richards J, Dhein J, Trauth BC, Ponsting H and Krammer PH (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen J. Biol. Chem 267. 10709-10715
23. Oltvai ZN, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
24. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Znang W-W, Kruzel E and Radinsky R (1995) Wild-type human p53 ana a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15. 3032-3040
25. Owen-Schaub LB, Yonehara S, Crump WL III and Grimm EA (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140: 197-205
26. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A and Biagini G (1983) Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 70: 447-453
27. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD and Bar-Eli M (1994) Terminal differentiation and apoptosis in experimental lung metastasis of human osteogenic sarcoma cells by wild type p53 Oncogene 9: 1877-1883
28. Ramqvist T, Magnusson KP, Wang Y, Szelely L, Klein G and Wiman KG (1993) Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53 Oncogene 8 1495-1500
29. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B and Libermann D (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798
30. Sentman C, Shutter J, Hockenbery D, Kanagawa O and Korsemeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888
31. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89: 4495-4499
32. Stalder T, Hahn S and Erb P (1994) Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J. Immunol. 152: 1127-1133
33. Strasser A, Harris AW and Cory S (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67. 889-899
34. Suda T, Takahashi T, Goldstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75 1169-1178
35. Th'ng KH, Garewal G, Keamey L, Rassool F, Melo JV, White H, Catovsky D, Foroni L, Luzzatto L and Goldman JM (1987) Establishment and characterization of three new malignant lymphoid cell lines. Int. J. Cancer 3989-3993
36. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin K-M and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
37. Ulrich MJ and Ley TJ (1990) Function of normal and mutated gamma-globin gene promoters in eleotroporated K562 erythroleukemia cells Blood 75: 990-999
38. Wang X, Pai J-T, Wiedenfeld EA, Medina JC, Slaughter CA, Goldstein JL and Brown MS (1995) Purification of an interleukin-1 beta converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains. J. Biol. Chem. 270: 18044-18050
39. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS and Goldstein JL (1996) Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15: 1012-1020
40. Wolf D and Rotter V (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells Proc. Natl. Acad. Sci. USA 82790-82794
41. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis. a discourse on the BCL2 family and cell death. Blood 88: 386-401
42. Yonish-Rouach E, Resnitzky D, Lotem S, Sachs L, Kimchi Aand Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345-347
43. Zhan Q-M, Fan S-J, Bae I, Guillouf C, Lieberman DA, O'Connor PM and Fornace AJ Jr (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis Oncogene 9: 3743-3751
44. Zhang W, Funk WD, Wright WE, Shay JW and Deisseroth AB (1993) Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene 8: 2555-2559
45. Zhang W, Guo X-Y, Hu G-Y, Liu W-B, Shay JW and Deisseroth AB (1994a) A temperature-sensitive mutant of human p53. EMSO J. 13: 2535-2544
46. Zhang W, Hu G and Deisseroth A (1992) Polymorphism atcodon 72 of the p53 gene in human acute myelogenous leukemia. Gene 117: 271-275
47. Zhang W, McClain CD, Gau J-P, Guo X-Y and Deisseroth AB (1994b). Hyperphosphorylaticn of p53 induced by okadaic acid attenuates its transcriptional activation function. Cancer Res. 54: 4448-4453
48. Zhang W, Randhawa GS, Gau J-P, Shay JW and Deisseroth AB (1995) The first intron of human H-ras is regulated by p53: Mediation of specific activation by a p53-binding element Int J Oncol. 7 1021-1028